BioAge Labs Statistics Share Statistics BioAge Labs has 35.85M
shares outstanding. The number of shares has increased by 6.48%
in one year.
Shares Outstanding 35.85M Shares Change (YoY) 6.48% Shares Change (QoQ) 0% Owned by Institutions (%) 56.25% Shares Floating 21.05M Failed to Deliver (FTD) Shares 336 FTD / Avg. Volume 0.16%
Short Selling Information The latest short interest is 2.4M, so 6.7% of the outstanding
shares have been sold short.
Short Interest 2.4M Short % of Shares Out 6.7% Short % of Float 7.87% Short Ratio (days to cover) 23.21
Valuation Ratios The PE ratio is -0.87 and the forward
PE ratio is -1.88.
BioAge Labs's PEG ratio is
0.04.
PE Ratio -0.87 Forward PE -1.88 PS Ratio 0 Forward PS 74.6 PB Ratio 0.19 P/FCF Ratio -1.2 PEG Ratio 0.04
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for BioAge Labs.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 12.86,
with a Debt / Equity ratio of 0.03.
Current Ratio 12.86 Quick Ratio 12.86 Debt / Equity 0.03 Debt / EBITDA -0.11 Debt / FCF -0.17 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-1.15M Employee Count 62 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by null% in the
last 52 weeks. The beta is 1.45, so BioAge Labs's
price volatility has been higher than the market average.
Beta 1.45 52-Week Price Change n/a 50-Day Moving Average 4.51 200-Day Moving Average 5.51 Relative Strength Index (RSI) 56.75 Average Volume (20 Days) 208,319
Income Statement
Revenue n/a Gross Profit n/a Operating Income -78.19M Net Income -71.11M EBITDA -78.19M EBIT -68.74M Earnings Per Share (EPS) -6.63
Full Income Statement Balance Sheet The company has 354.35M in cash and 8.7M in
debt, giving a net cash position of 345.64M.
Cash & Cash Equivalents 354.35M Total Debt 8.7M Net Cash 345.64M Retained Earnings -252.81M Total Assets 322.15M Working Capital 278.86M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -51.52M
and capital expenditures -366K, giving a free cash flow of -51.89M.
Operating Cash Flow -51.52M Capital Expenditures -366K Free Cash Flow -51.89M FCF Per Share -4.84
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
